Abstract
Full text links
Read article at publisher's site: https://doi.org/10.4049/jimmunol.180.5.3132
Read article for free, from open access legal sources, via Unpaywall: https://www.jimmunol.org/content/jimmunol/180/5/3132.full.pdf
References
Articles referenced by this article (54)
Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy.
Cancer Res, (20):5245-5249 1999
MED: 10537304
Increasing infiltration and activation of CD8+ tumor-infiltrating lymphocytes after eliminating immune suppressive granulocyte/macrophage progenitor cells with low doses of interferon gamma plus tumor necrosis factor alpha.
Cancer Immunol Immunother, (1):9-15 1994
MED: 8299123
Immunosuppressive networks in the tumour environment and their therapeutic relevance.
Nat Rev Cancer, (4):263-274 2005
MED: 15776005
Combining radiotherapy and immunotherapy: a revived partnership.
Int J Radiat Oncol Biol Phys, (3):655-666 2005
MED: 16199306
The role of IFN-gamma in tumor transplantation immunity and inhibition of chemical carcinogenesis.
Curr Opin Immunol, (2):148-154 2003
MED: 12633663
Immunopotentiating role of IFN-gamma in early and late stages of type 1 CD8 effector cell-mediated tumor rejection.
Clin Immunol, (1):70-84 2001
MED: 11141329
Synergistic effects of co-expression of the TH1 cytokines IL-2 and IFN-gamma on generation of murine tumor-reactive cytotoxic cells.
Int J Cancer, (5):628-634 1995
MED: 7768635
Show 10 more references (10 of 54)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.4049/jimmunol.180.5.3132
Article citations
Radiation drives tertiary lymphoid structures to reshape TME for synergized antitumour immunity.
Expert Rev Mol Med, 26:e30, 23 Oct 2024
Cited by: 0 articles | PMID: 39438247 | PMCID: PMC11505612
Review Free full text in Europe PMC
Cold and hot tumors: from molecular mechanisms to targeted therapy.
Signal Transduct Target Ther, 9(1):274, 18 Oct 2024
Cited by: 0 articles | PMID: 39420203 | PMCID: PMC11491057
Review Free full text in Europe PMC
Oncolytic Viruses as Reliable Adjuvants in CAR-T Cell Therapy for Solid Tumors.
Int J Mol Sci, 25(20):11127, 16 Oct 2024
Cited by: 0 articles | PMID: 39456909 | PMCID: PMC11508774
Review Free full text in Europe PMC
Revolutionizing Cancer Treatment: Recent Advances in Immunotherapy.
Biomedicines, 12(9):2158, 23 Sep 2024
Cited by: 0 articles | PMID: 39335671 | PMCID: PMC11429153
Review Free full text in Europe PMC
The Effects of Gynecological Tumor Irradiation on the Immune System.
Cancers (Basel), 16(16):2804, 09 Aug 2024
Cited by: 0 articles | PMID: 39199577 | PMCID: PMC11352652
Review Free full text in Europe PMC
Go to all (294) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor.
J Immunol, 174(12):7516-7523, 01 Jun 2005
Cited by: 589 articles | PMID: 15944250
USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.
Mol Cancer, 13:132, 31 May 2014
Cited by: 20 articles | PMID: 24884733 | PMCID: PMC4057584
Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
J Immunol, 172(3):1380-1390, 01 Feb 2004
Cited by: 35 articles | PMID: 14734713
IL-12 suppresses vascular endothelial growth factor receptor 3 expression on tumor vessels by two distinct IFN-gamma-dependent mechanisms.
J Immunol, 184(4):1858-1866, 08 Jan 2010
Cited by: 29 articles | PMID: 20061409 | PMCID: PMC3070472
Funding
Funders who supported this work.
NCI NIH HHS (1)
Grant ID: CA28332
NIAID NIH HHS (1)
Grant ID: AI07285